学术探索
学术期刊
新闻热点
数据分析
智能评审

ENHANCEMENT OF FLUOROURACIL THERAPY BY THE MANIPULATION OF TISSUE URIDINE POOLS

被引：37
作者：
DARNOWSKI, JW
HANDSCHUMACHER, RE
机构：
来源：
PHARMACOLOGY & THERAPEUTICS | 1989年 / 41卷 / 1-2期
关键词：
D O I：
10.1016/0163-7258(89)90115-0
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：381 / 392
页数：12
相关论文
共 113 条
[71]  
MARTIN DS, 1978, CANCER B HOUSTON, V30, P219
[72]  
MARTIN DS, 1984, CHEMOTHER F S, V4, P69
[73]  
MILLER EM, 1987, P AM ASSOC CANC RES, V28, P326
[74]   URIDINE REGULATION BY THE ISOLATED RAT-LIVER - PERFUSION WITH AN ARTIFICIAL OXYGEN CARRIER [J].
MONKS, A ;
CYSYK, RL .
AMERICAN JOURNAL OF PHYSIOLOGY, 1982, 242 (05) :R465-R470
[75]   EFFECT OF 5-BENZYLACYCLOURIDINE, A POTENT INHIBITOR OF URIDINE PHOSPHORYLASE, ON THE METABOLISM OF CIRCULATING URIDINE BY THE ISOLATED RAT-LIVER [J].
MONKS, A ;
AYERS, O ;
CYSYK, RL .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (13) :2003-2009
[76]  
MOYER JD, 1981, CANCER RES, V41, P3010
[77]  
MUGGIA FM, 1987, CANCER TREAT REP, V71, P253
[78]   PYRIMIDINE ACYCLONUCLEOSIDES, INHIBITORS OF URIDINE PHOSPHORYLASE [J].
NIEDZWICKI, JG ;
ELKOUNI, MH ;
CHU, SH ;
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1981, 30 (15) :2097-2101
[79]   5-BENZYLACYCLOURIDINE AND 5-BENZYLOXYBENZYLACYCLOURIDINE, POTENT INHIBITORS OF URIDINE PHOSPHORYLASE [J].
NIEDZWICKI, JG ;
CHU, SH ;
ELKOUNI, MH ;
ROWE, EC ;
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1982, 31 (10) :1857-1861
[80]   STRUCTURE ACTIVITY RELATIONSHIP OF LIGANDS OF THE PYRIMIDINE NUCLEOSIDE PHOSPHORYLASES [J].
NIEDZWICKI, JG ;
ELKOUNI, MH ;
CHU, SH ;
CHA, S .
BIOCHEMICAL PHARMACOLOGY, 1983, 32 (03) :399-415
3456789101112